Xaira Therapeutics Secures $1 Billion in Series A Funding for AI-Driven Drug Discovery
Trendline

Xaira Therapeutics Secures $1 Billion in Series A Funding for AI-Driven Drug Discovery

What's Happening? Xaira Therapeutics, a privately held biotechnology company established in 2023 and based in South San Francisco, CA, has successfully raised $1 billion in Series A funding. The company specializes in biotechnology research, drug discovery and development, and the application of art
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.